Last reviewed · How we verify
NCT05905900
Emergent Intravenous Dye Preparation for Acute Stroke Patients With a History of Intravenous Dye Allergy
trial testing Emergent IV Dye Preparation in Stroke in 50 participants. Status unknown.
18 January 2019
Quick facts
| Lead sponsor | Global Neurosciences Institute |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 January 2015 |
| Primary completion | 18 January 2019 |
| Estimated completion | 1 June 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Emergent IV Dye Preparation
Conditions studied
- Stroke — all drugs for Stroke →
- Dye Allergy — all drugs for Dye Allergy →
Sponsor
Global Neurosciences Institute
Who can join
Eligibility, any sex, with Stroke or Dye Allergy.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Adverse Reactions
Time frame: 24 Hours
Unwanted side effects of medication administration, including but not limited to itching, rash, mild shortness of breath etc.
Sponsor's own description
Our institution implemented a protocol to administer an emergent IV dye preparation for stroke alert patients requiring advanced neuroimaging. The emergent IV dye preparation consists of diphenhydramine 50 mg IV once, famotidine 20 mg IV once, and dexamethasone 10 mg IV once, followed immediately by Computed Tomography (CT) Angiography and/or CT Perfusion.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Addressing Stroke Care: Overcoming Contrast-Allergy Challenges With Rapid Intravenous Dye Preparation.
Greenberg K, Ross JA, Kurtz TA, Deans AE, et al · · 2025 · PMID 40951044 · DOI 10.7759/cureus.90098
Verify or expand the search:
- PubMed search for NCT05905900
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05905900 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Global Neurosciences Institute
- Last refreshed: 7 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05905900.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing